BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hou D, Wang M, Hu X, Wang Z, Zhang N, Lv G, Wang J, Wu X, Wang L, Wang H, Xu W. An activated excretion-retarded tumor imaging strategy towards metabolic organs. Bioactive Materials 2021. [DOI: 10.1016/j.bioactmat.2021.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Hou D, Xiao W, Wang J, Yaseen M, Wang Z, Fei Y, Wang M, Wang L, Wang H, Shi X, Cai M, Feng H, Xu W, Li L. OGA activated glycopeptide-based nano-activator to activate PKM2 tetramerization for switching catabolic pathways and sensitizing chemotherapy resistance. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lv MY, Xiao WY, Zhang YP, Jin LL, Li ZH, Lei Z, Cheng DB, Jin SD. In situ self-assembled peptide enables effective cancer immunotherapy by blockage of CD47. Colloids Surf B Biointerfaces 2022;217:112655. [PMID: 35785715 DOI: 10.1016/j.colsurfb.2022.112655] [Reference Citation Analysis]
3 Hou DY, Wang MD, Zhang NY, Xu S, Wang ZJ, Hu XJ, Lv GT, Wang JQ, Lv MY, Yi L, Wang L, Cheng DB, Sun T, Wang H, Xu W. A Lysosome-Targeting Self-Condensation Prodrug-Nanoplatform System for Addressing Drug Resistance of Cancer. Nano Lett 2022. [PMID: 35548949 DOI: 10.1021/acs.nanolett.2c00540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]